Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Daniel D. Long, San Francisco US
Daniel D. Long, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080255187 | 5-HT4 RECEPTOR AGONIST COMPOUNDS - The invention provides novel quinolinone-carboxamide 5-HT | 10-16-2008 |
| 20090023934 | Process for preparing an intermediate to opioid receptor antagonists - The invention provides an efficient method for preparing 3-endo-(8-azabicyclo[3.2.1]oct-3-yl)benzamide by hydrogenation, under controlled conditions, of an amino-protected 3-(8-azabicyclo[3.2.1 ]oct-2-en-3-yl)benzamide intermediate in which the amino-protecting group is removable by catalytic hydrogenation. | 01-22-2009 |
| 20090036483 | QUINOLINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS - The invention provides novel quinolinone-carboxamide 5-HT | 02-05-2009 |
| 20090062332 | Disubstituted alkyl-8-azabicyclo[3.2.1] octane compounds as mu opioid receptor antagonists - The invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula (I): | 03-05-2009 |
| 20090062333 | 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists - The invention provides 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds of formula (I): | 03-05-2009 |
| 20090062334 | Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists - The invention provides heteroarylene substituted 8-azabicyclo[3.2.1]octane compounds of formula (I): | 03-05-2009 |
| 20090062335 | Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists - The invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula (I): | 03-05-2009 |
| 20090137460 | Cross-linked glycopeptide-cephalosporin antibiotics - This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds. | 05-28-2009 |
| 20090149465 | AMINOTETRALIN COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS - The invention provides aminotetralin compounds of formula (I): | 06-11-2009 |
| 20090149535 | 3-CARBOXYPROPYL-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS - The invention provides 3-carboxypropyl-aminotetralin compounds of formula (I): | 06-11-2009 |
| 20090209582 | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists - The invention relates to benzimidazole-carboxamide 5-HT | 08-20-2009 |
| 20090247627 | AMINO- AND AMIDO-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS - The invention provides amino- and amido-aminotetralin compounds of formula (I): | 10-01-2009 |
| 20100035921 | 8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS - The invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula (I): | 02-11-2010 |
| 20100125092 | 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS - The invention relates to compounds of formula I: | 05-20-2010 |
| 20100152199 | HETEROARYLALKYL-8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS - The invention provides heteroarylene substituted 8-azabicyclo[3.2.1]octane compounds of formula (I): | 06-17-2010 |
| 20100197569 | CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS - This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds. | 08-05-2010 |
| 20100249186 | BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS - The invention relates to benzimidazole-carboxamide 5-HT | 09-30-2010 |
| 20100261716 | INDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS - The invention provides novel indazole-carboxamide 5-HT | 10-14-2010 |
| 20100285519 | QUINOLINONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS - The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds of Formula (I). The invention also provides pharmaceutical compositions comprising such compounds, the use such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds. Wherein; R | 11-11-2010 |
| 20100292223 | INDAZOLE-CARBOXAMIDE COMPOUNDS - The invention provides novel indazole-carboxamide 5-HT | 11-18-2010 |
| 20110118306 | 8-AZABICYCLO[3.2.1]OCTYL-2-HYDROXYBENZAMIDE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS - The invention provides 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds of formula (I): | 05-19-2011 |
| 20110124677 | AMIDOALKYL-8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS - The invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula | 05-26-2011 |
| 20110144152 | DISUBSTITUTED ALKYL-8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS - The invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula (I): | 06-16-2011 |
| 20110166355 | PROCESS FOR PREPARING AN INTERMEDIATE TO MU OPIOID RECEPTOR ANTAGONISTS - The invention provides an efficient method for preparing 3-endo-(8-azabicyclo[3.2.1]oct-3-yl)benzamide by hydrogenation, under controlled conditions, of an amino-protected 3-(8-azabicyclo[3.2.1]oct-2-en-3-yl)benzamide intermediate in which the amino-protecting group is removable by catalytic hydrogenation. | 07-07-2011 |